Citi Starts Acceleron Pharma (XLRN) at Neutral

September 29, 2016 8:12 AM EDT
Get Alerts XLRN Hot Sheet
Price: $29.20 -3.28%

Rating Summary:
    10 Buy, 2 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade XLRN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Citi initiated coverage on Acceleron Pharma (NASDAQ: XLRN) with a Neutral rating and a price target of $40.00.

For an analyst ratings summary and ratings history on Acceleron Pharma click here. For more ratings news on Acceleron Pharma click here.

Shares of Acceleron Pharma closed at $39.58 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities


Add Your Comment